Onward Medical NV

0
FRA:63E (Netherlands)  
€ 5.20 (0%) Nov 5
At Loss
P/B:
9.66
Market Cap:
€ 220.91M ($ 238.18M)
Enterprise V:
€ 206.17M ($ 222.29M)
Volume:
-
Avg Vol (2M):
1.57K
Trade In:

Business Description

Description
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injuries. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United States and four European markets: Germany, France, the UK, and the Netherlands to create a customer base.
Name Current Vs Industry Vs History
Cash-To-Debt 1.85
Equity-to-Asset 0.39
Debt-to-Equity 0.94
Debt-to-EBITDA -0.51
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 68.67
9-Day RSI 58.62
14-Day RSI 56.09
6-1 Month Momentum % 7.13
12-1 Month Momentum % 64.24

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.65
Quick Ratio 3.65
Cash Ratio 3.36
Days Payable 1557.42

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -72.3
Shareholder Yield % -9.62
Name Current Vs Industry Vs History
ROE % -149.47
ROA % -70.53
ROIC % -269.31
3-Year ROIIC % -322.05
ROC (Joel Greenblatt) % -1776.58
ROCE % -82.73

Financials

FRA:63E's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Onward Medical NV Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -1.09
Beta 0.58
Volatility % 48.14
14-Day RSI 56.09
14-Day ATR (€) 0.215155
20-Day SMA (€) 5.0775
12-1 Month Momentum % 64.24
52-Week Range (€) 1.995 - 6.54
Shares Outstanding (Mil) 44.63

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Onward Medical NV Filings

Filing Date Document Date Form
No Filing Data

Onward Medical NV Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Onward Medical NV Frequently Asked Questions

What is Onward Medical NV(FRA:63E)'s stock price today?
The current price of FRA:63E is €5.20. The 52 week high of FRA:63E is €6.54 and 52 week low is €2.00.
When is next earnings date of Onward Medical NV(FRA:63E)?
The next earnings date of Onward Medical NV(FRA:63E) is .
Does Onward Medical NV(FRA:63E) pay dividends? If so, how much?
Onward Medical NV(FRA:63E) does not pay dividend.

Press Release

Subject Date
No Press Release